Comparative study between the effects of metformin monotherapy in obese and non-obese patients with polycystic ovary syndrome

Document Type : Original Article

Author

Department of Obstetrics and Gynecology and Minia Infertility Research Unit, Minia University, Egypt.

Abstract

Objective:7RFRPSDUHWKHHI¿FDF\RIPHWIRUPLQPRQWKHUDS\LQLPSURYHPHQWRIWKH
clinical and biochemical parameters, ovulation and pregnancy rates in obese and non
obese patients with polycystic ovary syndrome.
Materials & Methods : A prospective comparative study in Minia University infertility
clinic comprised of 100 infertile women who were diagnosed as clomiphene citrate resistant polycystic ovary syndrome at the period startingIURP1RYHPEHUWR$XJXVW7KHSDWLHQWVZHUHGLYLGHGLQWRJURXSV*URXS 2 LQFOXGHGSDWLHQWVZLWK
%0,•NJPDQG*URXS 1 LQFOXGHGSDWLHQWVZLWK%0,”NJP%RWKJURXSV
received metformin 850 mg tablet twice daily for 12 weeks. The primary outcomes were
the ovulation rate, the degree of menstrual regularity , the change of the patients‘ clinical
DQGELRFKHPLFDOSUR¿OHDIWHUWKUHHPRQWKVRIPHWIRUPLQWUHDWPHQWLQFOXGLQJWKHFKDQJHV
LQ/+)6+UDWLR7KHVHFRQGDU\RXWFRPHZDVWKHSUHJQDQF\UDWH
Results :7KHUHZDVDVWDWLVWLFDOO\VLJQL¿FDQWLPSURYHPHQWDVUHJDUGVSUHDQGSRVWWUHDWPHQWFRQFHUQLQJUHJXODULW\RIWKHF\FOH S DFQH S DQG/+)6+UDWLR
S  DQGQRVWDWLVWLFDOO\VLJQL¿FDQWLPSURYHPHQWDVUHJDUGKLUXVWLVPEHWZHHQERWK
JURXSV,QDGGLWLRQWKHUHZDVDVWDWLVWLFDOO\VLJQL¿FDQWLPSURYHPHQWDVUHJDUGVSUHDQG
post-treatment concerning regularity of the cycle (p=0.0001 & 0.0002) , acne (p=0,028
 DQG/+)6+UDWLR S   DQGQRVWDWLVWLFDOO\VLJQL¿FDQWGHFUHDVH
DVUHJDUGKLUXVWLVPLQERWKJURXSV+RZHYHUWKHUHZHUHQRVWDWLVWLFDOO\VLJQL¿FDQWGLIferences between the two groups concerning the ovulation and pregnancy rates after
treatment.
Conclusions : Metformin alone may be an effective drug for restoration of menstrual irUHJXODULWLHV/+)6+UDWLRWUHDWPHQWRIDFQHLQGXFLQJRYXODWLRQDQGLQFUHDVHSUHJQDQF\
UDWHVLQFORPLSKHQHFLWUDWHUHVLVWDQWSRO\F\VWLFRYDU\V\QGURPH1RQREHVHSDWLHQWVUHVSRQGHGEHWWHUEXWVWDWLVWLFDOO\QRQVLJQL¿FDQWWKDQREHVHSDWLHQWV)XUWKHUUDQGRPL]HG
FRQWUROOHGVWXGLHVRQODUJHQXPEHURISDWLHQWVDUHUHTXLUHGWRFRPSDUHHI¿FDF\RIPHWformin in obese and non obese PCOS patients.

Keywords